Ledger.Open graph →
SEC Form D · Amendment · filed November 1, 2019

Cocoon Biotech Inc

Offering
—
Sold
$4.5M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
Cambridge, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (11)

Annalisa Jenkins · Cambridge, MADirectorAilis Tweed-Kent · Cambridge, MAExec · DirectorMary Thistle · Cambridge, MADirectorJoseph Hernon · San Juan, Puerto RicoExec · DirectorBrandon J. Harris · Dallas, TXDirectorTighe J. Reardon · La Jolla, CADirectorGrace Colon · Mountain View, CADirectorCastleKnight Fund GP LLC · New York, NYExec · DirectorShawn H. Colo · Williston, VTDirectorAaron Levy · Austin, TXDirectorGrace Colon · Mountain View, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗